ARDX
(NASDAQ)Ardelyx, Inc.
$5.13-- (--)
Loading... - Market loading
Ardelyx (ARDX) Stock Price & Financial Analysis
Ardelyx Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$4.97 - $5.15
52-Week High$8.40
52-Week Low$4.08
Open$5.00
Volume2.07M
Average Volume (3M)4.16M
Market Cap1.26B
Shares Outstanding245.86M
Price to Sales (P/S)2.95
Price to Book (P/B)8.49
EV/EBITDA-48.06
Revenue (TTM)427.68M
Net Income (TTM)-58.06M
Free Cash Flow (TTM)-37.50M
EPS (TTM)$-0.24
Profit Margin-13.58%
Operating Margin-8.75%
Return on Equity (ROE)-39.07%
Debt to Equity1.38
50-Day MA$5.69
200-Day MA$6.03
52-Week Change16.86%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$4.97 - $5.15
52-Week High$8.40
52-Week Low$4.08
Open$5.00
Volume2.07M
Average Volume (3M)4.16M
Market Cap1.26B
Shares Outstanding245.86M
Price to Sales (P/S)2.95
Price to Book (P/B)8.49
EV/EBITDA-48.06
Revenue (TTM)427.68M
Net Income (TTM)-58.06M
Free Cash Flow (TTM)-37.50M
EPS (TTM)$-0.24
Profit Margin-13.58%
Operating Margin-8.75%
Return on Equity (ROE)-39.07%
Debt to Equity1.38
50-Day MA$5.69
200-Day MA$6.03
52-Week Change16.86%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Ardelyx
What is the current stock price for ARDX?
As of the latest trading session, ARDX stock trades at $5.13. The 52-week range is $4.08–$8.40, with a day range of $4.97–$5.15.
What is the P/E ratio for ARDX?
The P/E ratio (Price-to-Earnings) for ARDX is shown in the Key Statistics section. This valuation metric helps compare Ardelyx, Inc. to industry peers.
Does ARDX pay dividends?
Ardelyx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARDX?
Based on 6 analysts, the consensus for ARDX is Buy.
What is the market cap of ARDX?
Ardelyx's market capitalization is $1.26B, classifying it as a small-cap company. Ardelyx operates in the Healthcare sector within the Biotechnology industry.